CVS Health's stock surged 5.84% in pre-market trading on Tuesday, marking a significant upward movement for the healthcare insurer.
The sharp increase follows an announcement by the Centers for Medicare & Medicaid Services (CMS) that it finalized a 2.48% average increase in payments to private insurers offering Medicare Advantage plans for 2027. This final rate is substantially higher than the minimal 0.09% hike proposed in January, providing relief to the sector and driving a broad rally among health insurance stocks.
Investors reacted positively to the news, which is expected to result in more than $13 billion in additional Medicare Advantage payments to plans next year. The decision pauses changes to the risk adjustment model, giving insurers more predictability for future medical costs and reversing the negative market sentiment that followed the initial low proposal earlier this year.
Comments